Insilico Medicine
Insilico Medicine
insilico.com

Locations

Boston, MA, USA

industry

Biotechnology · Data and Analytics · DeepTech · Health · Software

Size

201-1000 employees

Stage

Series C+

founded in

2014

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Something looks off?
Open jobs at Insilico Medicine

On-site & Remote